To investigate the clinical significance of INPP5A as a therapeutic target, we examined the steady-state levels of IP4 in UM patient-derived xenografts (PDXs) and patients’ tumor samples (Fig. 7e–g and Extended Data Fig. 10e,f). This evidence concerns the gene INPP5A and neoplasm.